Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.24.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock and Capital in Excess of Par Value, Shares
Common Stock and Capital in Excess of Par Value, Amount
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Jun. 30, 2023   136,750      
Beginning balance at Jun. 30, 2023 $ 2,919,753   $ 2,107,663 $ 848,431 $ (36,341)
Increase (Decrease) in Stockholders' Equity          
Net income 741,375     741,375  
Other comprehensive income (loss) (13,097)       (13,097)
Net issuance under employee stock plans (in shares)   173      
Net issuance under employee stock plans $ (68,237)   (68,237)    
Repurchase of common stock (in shares) (956) (956)      
Repurchase of common stock $ (459,093)   (14,722) (444,371)  
Cash dividends and dividend equivalents declared (179,256)     (179,256)  
Stock-based compensation expense 48,772   48,772    
Ending balance (in shares) at Sep. 30, 2023   135,967      
Ending balance at Sep. 30, 2023 2,990,217   2,073,476 966,179 (49,438)
Beginning balance (in shares) at Jun. 30, 2024   134,425      
Beginning balance at Jun. 30, 2024 3,368,328   2,280,133 1,137,270 (49,075)
Increase (Decrease) in Stockholders' Equity          
Net income 945,851     945,851  
Other comprehensive income (loss) 23,571       23,571
Net issuance under employee stock plans (in shares)   134      
Net issuance under employee stock plans $ (72,245)   (72,245)    
Repurchase of common stock (in shares) (740) (740)      
Repurchase of common stock $ (570,936)   (12,536) (558,400)  
Cash dividends and dividend equivalents declared (196,555)     (196,555)  
Stock-based compensation expense 61,700   61,700    
Ending balance (in shares) at Sep. 30, 2024   133,819      
Ending balance at Sep. 30, 2024 $ 3,559,714   $ 2,257,052 $ 1,328,166 $ (25,504)